HIV Policy & Programs

Your Federal Workforce Cares


Editor’s Note: As 2014 comes to an end, we continue to reflect on personal perspectives. The below video features voices from federal staff on their commitment to HIV/AIDS On the first day of the 2014 U.S. Conference of AIDS (USCA), Dr. Laura Cheever, head of the HRSA HIV/AIDS Bureau, and other federal agency leaders came together for a…

We Need Every Tool to End HIV


Editor’s Note: As we reflect on personal perspectives from 2014,  we would like to share this blog that has been cross-posted from . For more information on PrEP, visit HIV-negative gay men have a responsibility to use every tool at their disposal, including PrEP, to stay negative. I’m a PrEPer. I am HIV-negative, but I am taking an…

A Personal Perspective from Dr. Timothy Harrison

Tim Harrison Reflection

Editor’s Note: As we near the end of 2014, we reflect on some of the  personal perspectives we have shared throughout the year. Today, we want to share with you Dr. Timothy Harrison’s personal story and his commitment to working to reduce the disparities across the HIV care continuum.  Many of our colleagues in the…

Looking Ahead to 2015


As 2014 comes to a close and we prepare to celebrate the potential of the new year, Dr. Ronald Valdiserri, Deputy Assistant Secretary for Health, Infectious Diseases, shares his thoughts on the year ahead in this video message. Dr. Valdiserri, who leads efforts to implement the National HIV/AIDS Strategy and the Viral Hepatitis Action Plan,…

2014 Viral Hepatitis Year-in-Review and Looking to 2015

Ronald Valdiserri

2014 has been a year of both opportunities and challenges in the fight against viral hepatitis. In May, the World Health Assembly passed a new resolution  [PDF 151 KB] on viral hepatitis, urging member states to develop and implement coordinated, national strategies for preventing, diagnosing and treating viral hepatitis.  Our nation’s own comprehensive viral hepatitis strategy,…

FDA Commissioner Margaret A. Hamburg’s statement on FDA’s blood donor deferral policy for men who have sex with men


The U.S. Food and Drug Administration is a science-based regulatory agency that works to protect and promote the public health. In this role, it is our responsibility to regulate the blood supply and to help ensure its continued safety for the patients who receive these life-saving products. Over the past several years, in collaboration with…

Douglas Brooks: World AIDS Day & New Year’s Reflection


Javascript and flash are required to play this audio file.

Download MP3
Douglas Brooks

As 2014 draws to a close, we sat down with Douglas Brooks, Director of the White House Office of National AIDS Policy (ONAP), to talk about his reflections on the White House’s World AIDS Day 2014 event and his thoughts about the work ahead in 2015 to move closer to an AIDS-free generation. In his review…

FDA approves Viekira Pak to treat hepatitis C


The U.S. Food and Drug Administration today approved Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat patients with chronic hepatitis C virus (HCV) genotype 1 infection, including those with a type of advanced liver disease called cirrhosis. Hepatitis C is a viral disease that causes inflammation of the liver that…